Your browser doesn't support javascript.
loading
Bothrops snakebites in the Amazon: recovery from hemostatic disorders after Brazilian antivenom therapy
Oliveira, Sâmella Silva de; Alves, Eliane Campos; Santos, Alessandra dos Santos; Nascimento, Elizandra Freitas; Pereira, João Pedro Tavares; Silva, Iran Mendonça da; Sachett, Jacqueline; Ibiapina, Hiochelson Najibe dos Santos; Sarraf, Lybia Kássia Santos; Bernal, Jorge Carlos Contreras; Freitas-de-Sousa, Luciana Aparecida; Colombini, Mônica; Marques, Hedylamar Oliveira; Lacerda, Marcus Vinicius Guimarães de; Moura-da-Silva, Ana Maria; Fan, Hui Wen; Ferreira, Luiz Carlos de Lima; Sano-Martins, Ida Sigueko; Monteiro, Wuelton Marcelo.
Affiliation
  • Alves, Eliane Campos; Instituto Butantan. Laboratório de Imunopatologia.
  • Santos, Alessandra dos Santos; Instituto Butantan. Laboratório de Imunopatologia.
  • Nascimento, Elizandra Freitas; Instituto Butantan. Laboratório de Imunopatologia.
  • Pereira, João Pedro Tavares; Instituto Butantan. Laboratório de Artrópodes.
  • Silva, Iran Mendonça da; Instituto Butantan. Laboratório de Fisiopatologia.
Clin. Toxicol. ; 58(4): 266-274, 2020.
Article in En | SES-SP, SESSP-IBPROD, SES-SP | ID: but-ib17406
Responsible library: BR78.1
Localization: BR78.1
ABSTRACT

Introduction:

Bothrops atrox snakebites are a major public health problem in the Amazon region and also cause hemostatic disorders. In this study, we assessed the recovery from hemostatic disorders in Bothrops snakebite patients after being given antivenom therapy.

Methods:

This is a prospective study of Bothrops snakebite patients (n=100) treated at the Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazilian Amazon, between January 2016 and December 2017. Blood samples were taken for the measurement of venom concentrations, platelets, clotting time and factors of patients on admission, 12, 24 and 48h after antivenom therapy, and taken again on discharge. The presence of systemic bleeding was recorded during the follow-up.

Results:

On admission, systemic bleeding was observed in 14% of the patients. Thrombocytopenia was noted in 10% of the patients. A total of 54% of the patients presented unclottable blood with low levels of fibrinogen and alpha 2-antiplasmin, and high levels of fibrin/fibrinogen degradation product (FDP) and D-dimers. Unclottable blood and systemic bleeding were overcome in most patients 12h after the antivenom therapy. Three patients developed systemic bleeding 48h after antivenom therapy. Levels of fibrinogen and alpha 2-antiplasmin, FDP and D-dimer returned to normal around 48h after the treatment or on discharge. The frequency of thrombocytopenia with high mean platelet volume increased in the first 24h after antivenom therapy, and decreased on discharge. Bothrops venom levels in patients decreased 12h after antivenom therapy and were not correlated with coagulation and fibrinolytic parameters. There were no deaths.

Conclusion:

Laboratorial parameters of coagulopathy returned to normal values within 48h after the antivenom therapy until discharge. A few patients still presented bleeding signs within 48h after beginning antivenom therapy. However, the Brazilian antivenom was able to overcome the hemostatic disorders in these cases of envenomation.
Full text: 1 Collection: 06-national / BR Database: SES-SP / SESSP-IBPROD Language: En Journal: Clin. Toxicol. Year: 2020 Document type: Article
Full text: 1 Collection: 06-national / BR Database: SES-SP / SESSP-IBPROD Language: En Journal: Clin. Toxicol. Year: 2020 Document type: Article
...